Evidence map›Paper›PMID 42510153›Full record

ReviewDiagnostics (Basel, Switzerland)2026

Percutaneous Kidney Biopsy: Indications, Technique, and Peri-Procedural Management-A Narrative Review.

Saud Abdulelah O Alsaleh, Mariam Omar Shikshok, Ahmed Abdel-Aal, Ammar Almehmi

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Saud Abdulelah O AlsalehDepartment of Medicine and Radiology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.ORCID 0000-0002-9456-3335
Mariam Omar ShikshokFaculty of Medicine, University of Aleppo, Aleppo 12212, Syria.
Ahmed Abdel-AalDepartment of Interventional Radiology, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Ammar AlmehmiDepartment of Medicine and Radiology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Percutaneous kidney biopsy (PKB) is an essential tool in the nephrologist's armamentarium that plays a major role in establishing the diagnosis, monitoring response to interventions and providing prognostication. Over the last few decades, the technique of PKB has evolved from a blind procedure with a high complication rate to an image-guided procedure with substantially reduced but still clinically relevant complication rates, with major bleeding reported in approximately 1-6% of biopsies in contemporary series. With appropriate pre-procedure planning, patient selection, and experienced operators, PKB generally has a low rate of major complications and a high diagnostic yield, while clinicians must remain vigilant for bleeding and other adverse events. In this narrative review, we summarize current indications, contraindications, technical considerations, and complication mitigation strategies for PKB, integrating contemporary guideline recommendations and key observational studies to support bedside decision-making. Further, we review details pertaining to peri-procedure protocols. Special populations that require PKB such as morbid obesity, pregnancy, elderly, single kidney and anatomic abnormalities are discussed as well. Alternative approaches to performing PKB, when PKB is infeasible or challenging, are briefly covered in this review.

Indexed as

complicationshematuriainterventional nephrologykidney biopsypercutaneous renal biopsyultrasound guidance

Identifiers

PMID42510153
PMCPMC13408724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.